Dimerix signs up first patient for 'highly significant' paediatric clinical trial
Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3 clinical trial in a major next step for the research.The trial will investigate the efficacy of DMX-200 in children aged 12 to 17 with focal seg...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KMD | Ann: Lapse of Performance Rights | 19/12/24 | 0 | 42 | |||
|
|||||||
KMD | Ann: Notification of issue of Performance Rights | 13/12/24 | 0 | 75 | |||
|
|||||||
KMD | Ann: KMD Brands announces Release of Climate-Related Disclosure | 29/11/24 | 0 | 68 | |||
|
|||||||
KMD | Ann: Ongoing Disclosure Notice - Philip Bowman | 27/11/24 | 0 | 62 | |||
|
|||||||
KMD | Ann: Results of Annual Meeting | 19/11/24 | 0 | 65 | |||
|
|||||||
KMD | Ann: KMD Brands Limited Annual Shareholders Meeting | 19/11/24 | 0 | 81 | |||
|
|||||||
KMD | Ann: KMD Brands Trading Update | 19/11/24 | 0 | 73 | |||
|
|||||||
KMD | Ann: Ongoing Disclosure Notice - Abby Foote | 01/11/24 | 0 | 81 | |||
|
See All Discussions